UK – New COVID-10 guidelines for CKD and interstitial lung disease

The National Institute for Health and Care Excellence has published two new rapid COVID-19 guidelines for chronic kidney disease (CKD) and interstitial lung disease.

The group said the guidelines aim to help healthcare professionals decide what care should be provided for people without COVID-19 infection or with confirmed or suspected infection safely while making the best use of NHS resources.

The guideline on CKD recommends that patients, including those who have symptoms of COVID-19, should be advised to continue taking their medicines as normal unless advised to stop by their healthcare professional.

Those who are stable on treatment should be assessed to determine whether it is safe to reduce the frequency of routine kidney function tests, ‘taking into account any comorbidities and whether their CKD is progressive’…